Clinical Ink is a global clinical technology company transforming clinical development through its innovative suite of solutions including Direct Data Capture (DDC), eSource, electronic Patient Reported Outcomes (ePRO), and electronic Clinical Outcome Assessments (eCOA). Their configurable technology platform, supported by a team of therapeutic area experts, enables pharmaceutical sponsors and CROs to efficiently collect high-quality data directly from sites, clinicians, and patients, whether in-person or remotely. Clinical Ink aims to simplify and accelerate the clinical trial process, ultimately bringing new treatments to patients faster.
The Blue Bell headquarters serves as Clinical Ink's primary hub for corporate strategy, global operations management, product innovation and development, engineering, and administrative functions.
The Blue Bell office is a modern facility equipped with advanced technology infrastructure, designed to support agile development and cross-functional teamwork. It likely features collaborative workspaces, state-of-the-art meeting rooms, and amenities fostering innovation.
Clinical Ink's Blue Bell headquarters fosters a collaborative, innovative, and mission-driven environment. The culture emphasizes improving clinical trials through technology, encouraging employees to be proactive, solution-oriented, and quality-focused in a dynamic, fast-paced setting. There's a strong focus on professional development and contributing to meaningful advancements in healthcare.
The headquarters in Blue Bell, PA, strategically positions Clinical Ink within a prominent life sciences and pharmaceutical hub. This location offers access to a rich talent pool, proximity to key industry partners, and fosters engagement with the broader biotech ecosystem, supporting its growth and leadership in clinical trial technology.
Clinical Ink supports clinical trials worldwide, offering its technology platform and services across North America, Europe, and the Asia-Pacific region. Their global operations include multilingual platform capabilities, localized customer support, and infrastructure to manage data capture, patient engagement, and trial oversight for international studies, ensuring compliance with diverse regulatory landscapes.
550 E. Township Line Road, Suite 200
Blue Bell
PA
USA
Address: Winston House, Basingstoke, RG21 8DZ, United Kingdom
To deliver localized expertise and timely support for European clients and clinical trial sites, ensuring adherence to regional regulatory requirements and facilitating seamless trial execution across diverse European markets.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Clinical ink' leadership includes:
Clinical ink has been backed by several prominent investors over the years, including:
Over the past 12 months, Clinical Ink has significantly strengthened its leadership team with strategic appointments in key C-suite roles, including Chief People Officer, Chief Commercial Officer, Chief Product Officer, and Chief Technology Officer, signaling a focus on scaling operations, driving commercial growth, and advancing its technology platform. No public announcements regarding executive departures were noted during this period.
Discover the tools Clinical ink uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Clinical Ink commonly utilizes email formats such as the employee's first initial followed by their last name (e.g., jdoe@clinicalink.com) or first name separated by a period from the last name (e.g., jane.doe@clinicalink.com). Variations may exist based on department or region.
[first_initial][last]@clinicalink.com
Format
jdoe@clinicalink.com
Example
75%
Success rate
Business Wire • December 5, 2023
Clinical Ink, a global clinical trial technology company, today announced the appointment of Nathan Johnson as Chief Technology Officer (CTO). Johnson will oversee the company’s technology strategy and development, focusing on enhancing its industry-leading eSource, DDC, and patient engagement solutions....more
PR Newswire • October 24, 2023
Clinical Ink and Tasso, Inc. announced a new partnership to integrate Tasso's remote, patient-centric blood collection technology with Clinical Ink's Lunexis™ eSource platform. This collaboration aims to simplify data collection in decentralized clinical trials (DCTs) and improve the patient experience....more
Business Wire • September 12, 2023
Clinical Ink announced the appointment of Joan Odisho as Chief Product Officer. Odisho will be responsible for leading the company’s product strategy, ensuring Clinical Ink’s solutions continue to meet the evolving needs of clinical development....more
Business Wire • May 16, 2023
Clinical Ink today announced the appointments of Aryn Knight as Chief People Officer (CPO) and Tim Breen as Chief Commercial Officer (CCO). These leadership additions are poised to support the company's continued growth and market leadership in clinical trial technology....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Clinical ink, are just a search away.